Antioxidant effects of Artemis sphaerocephala Krasch. gum, on streptozotocin-induced type 2 diabetic rats

Food Hydrocolloids

Volumn 25, Issue 2, 2011, Pages 207-213

  Hu, Xin Zhong ^a   Xing, Xiao Hui ^a   Zhang, Zheng Mao ^a   Wu, Rui Qin ^a   Guo, Qingbin ^a   Cui, Steve W ^a,b   Wang, Qi ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b GUELPH RESEARCH AND DEVELOPMENT CENTRE   (Canada)

Author keywords

Antioxidant effects; Artemis sphaerocephala Krasch. gum; STZ; Type 2 diabetes

Indexed keywords

ANIMALIA; ASTERACEAE; RATTUS;

EID: 77956613971     PISSN: 0268005X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodhyd.2009.12.006     Document Type: Article

References (35)

1. Berijihangeriletu, Haidubu, Narisu, Arong, Zhaorigetu, & Songlin. (February 9th, 2005). The application of white Shahao polysaccharides in drug and health products for lowering blood lipids. C.N. patent CN1575799.
2. Bhatia S., Shukla R., Venkata S., Kaur J., Madhava K. Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clinical Biochemistry 2003, 36:57-62.
3. Ceriello A., Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arteriosclerosis, Thrombosis, and Vascular Biology 2004, 24:816-823.
4. Cheeseman K.H., Slater T.F. An introduction to free radical biochemistry. British Medical Bulletin 1993, 49:481-493.
5. Coskun O., Kanter M., Korkmaz A., Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Food Chemistry 2008, 108:965-972.
6. Damon R. Diabetes and periodonatal disease. Journal of Periodontology 1991, 62:161-163.
7. Devasena T., Lalitha S., Padma K. Lipid peroxidation, osmotic fragility and antioxidant status in children with acute post-streptococcal glomerulonephritis. Clinica Chimica Acta 2001, 308:155-161.
8. Elgebaly M., Portik-Dobos V., Sachidanandam K. Differential effects of ETA and ETB receptor antagonism on oxidative stress in type 2 diabetes. Vascular Pharmacology 2007, 47:125-130.
9. Feillet-Coudray C., Rock E., Coudray C., Grzelkowska K., Azais-Braesco V., Dardevet D., et al. Lipid peroxidation and antioxidant status in experimental diabetes. Clinica Chimica Acta 1999, 284:31-43.
10. Guzik T.J., Mussa S., Gastaldi D., Sadowski J., Ratnatunga C., Pillai R., et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002, 105(14):1656-1662.
11. Hu X.Z., Xing X.H. Medical effect of Shahao in China. Recent Progress in Medicinal Plants 2009, 27:221-240.
12. Hu X.Z., Yang Y.L., Du S.K., Zhang G.Q. Effect of Artemisia sphaerocephala Kraschen seed powder and vital gluten on the processing quality of oat whole meal. Transactions of the Chinese Society of Agricultural Engineering 2006, 22:230-232.
13. + ATPase activity in kidney, brain and erythrocyte membrane in alloxan diabetic rats. Indian Journal of Experimental Biology 1992, 30:26-32.
14. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress and antioxidants: a review. Journal of Biochemical and Molecular Toxicology 2003, 17:24-38.
15. Mikio S., Hideyuki Y., Tsutomu H. High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy. Nutrition, Metabolism and Cardiovascular Diseases 2006, 16:477-484.
16. Mohamed A.K., Bierhaus A., Schiekofer S. The role of oxidative stress and NF(B) activation in late diabetic complications. Biological Factors 1999, 10:175-179.
17. Mokuda O., Okazaki R., Sakamoto Y. The early phase of calcipenia-induced parathyroid hormone secretion is blunted in vascularly perfused parathyroid glands of streptozotocin-diabetic rats. Diabetes & Metabolism 2001, 27:129-131.
18. Nielsen F., Mikkelsen B.B., Nielsen J.B., Andersen H.L., Grandjean P. Plasma malondialdehyde as a biomarker for oxidative stress: reference interval and effects of life style factors. Clinical Chemistry 1997, 43:1209-1214.
19. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979, 95:351-358.
20. Oyanagui Y. Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Analytical Biochemistry 1984, 142:290-296.
21. Rakieten N., Rakieten M.L., Nadkarni M.V. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemotherapy Reports 1963, 29:91-98.
22. Rasilainen S., Jenni M.N., Levonen A.L., Otonkoski T., Lapatto R. Dose-dependent cysteine-mediated protection of insulin producing cells from damage by hydrogen peroxide. Biochemical Pharmacology 2002, 63:1297-1304.
23. Reed M.J., Meszaros K., Entes L.J., Claypool M.D., Pinkett J.G., Gadbois T.M., et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000, 49:1390-1394.
24. Ruiz L.B., Leal A., Martin C., Martinez R., Lacort M. Effects of estrogens on the redox chemistry of iron: a possible mechanism of the antioxidant action of estrogens. Steroids 1995, 60:780-783.
25. Slatter D.A., Bolton C.H., Bailey A.J. The importance of lipid derived malondialdehyde in diabetes mellitus. Diabetologia 2000, 43:550-557.
26. Srinivasan K., Viswanad B., Asrat L., Kaul C.L., Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacological Research 2005, 52:313-320.
27. Su, W., Sun, L., Dong, L., Han, J., & Zhai, L. (December 31, 2008). Use of Shahao polysaccharide gum in drugs for lowering body weight and blood lipids. C.N. patent CN101332207.
28. Telci A., Cakatay U., Kayali R., Erdogan C., Orhan Y., Sivas A. Oxidative protein damage in plasma of type 2 diabetic patients. Hormone and Metabolic Research 2000, 32:40-43.
29. Vucic M., Gavella M., Bozikov V., Ashcroft S.J.H., Rocic B. Superoxide dismutase activity in lymphocytes and polymorphonuclear cells of diabetic patients. European Journal of Clinical Chemistry 1997, 35:517-521.
30. Wei M.S., Tu C.Z. Preliminary study of Artemis sphaerocephala Krasch seed coating polysaccharide and its sand-fixing test. Journal of Integrative Plant Biology 1980, 22:300-301. (in Chinese).
31. Wei Y.M., Zhang G.Q., Wang L.H. Effect of Artemisia sphaerocephala Kraschen on the rheological properties of buckwheat flour. Journal of the Chinese Cereals and Oils Association 1996, 11:28-31. (in Chinese).
32. Yamamoto T., Takakura S., Kawamura I., Seki J., Goto T. The effect of zenarestat, an aldose reductase inhibitor, on minimal Fwave latency and nerve blood flow in streptozotocin-induced diabetic rats. Life Science 2001, 68:1439-1448.
33. Zhang F., Ye C., Li G. The rat model of type 2 diabetic mellitus and its glycometabolism characters. Experiment of Animal 2003, 52:401-407.
34. Zhang, J., Hou, T., Wang, Y., Yao, J., Cheng, F., Zeng, J., et al. (August 17, 2005). Preparation and application of Shahao polysaccharides that reduce blood glucose. C.N. patent 1654481.
35. Zhao C.X., Huang Z.S. Preliminary study of the drought-resistance structure of main xerophytic plants in Tenggeli Desert. Journal of Integrative Plant Biology 1981, 4:281. (in Chinese).